Skip to content

Study · Non-randomized trial · 1989

1 result

[Characteristics of secondary immunologic deficiency in children with chronic hepatitis B and the methods of its correction].

Gol'zand IV, Egorov VB, Popova IA

Terapevticheskii arkhiv1 Jan 1989

PMID2786265 (opens in a new tab)PepBankPUB-02786265
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In children with chronic hepatitis B, thymalin was effective when cold autolymphocytotoxins were absent or had low activity.

    In plain wordsIn children with chronic hepatitis B, thymalin was effective when cold autolymphocytotoxins were absent or had low activity.

    Peptide
    Thymalin
    Outcome
    Not applicableTreatment effectiveness by autolymphocytotoxin status
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The treatment with thymalin proved effective in patients with the lack of cold autolymphocytotoxins or in those with low activity of the latter ones.
    1 context sentence
    Summary · context
    A study was made of the immune system of patients with chronic HB-viral infection who showed the signs of secondary immundeficiency.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.